| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023300789 |
| P356 | DOI | 10.1038/SJ.NPP.1301149 |
| P698 | PubMed publication ID | 16823383 |
| P50 | author | Jakub Fichna | Q22115026 |
| Anna Janecka | Q61093660 | ||
| Mariola Piestrzeniewicz | Q123124220 | ||
| Jean Claude do-Rego | Q123124232 | ||
| P2093 | author name string | Jean Costentin | |
| P2860 | cites work | Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands | Q24561925 |
| Forced swimming test in mice: a review of antidepressant activity | Q28299108 | ||
| Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses | Q28510086 | ||
| Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects | Q31911131 | ||
| Functional neuroimaging studies of depression: the anatomy of melancholia | Q32089512 | ||
| Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density | Q33838460 | ||
| Buprenorphine treatment of refractory depression | Q34058674 | ||
| Identification of two related pentapeptides from the brain with potent opiate agonist activity | Q34134593 | ||
| A potent and selective endogenous agonist for the mu-opiate receptor | Q34420509 | ||
| Anatomy of CNS opioid receptors | Q34660554 | ||
| Isolation and distribution of endomorphins in the central nervous system | Q34787913 | ||
| The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice | Q36125191 | ||
| Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? | Q37923927 | ||
| Pharmacological mechanisms of opioid analgesics. | Q39496101 | ||
| Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment | Q39998916 | ||
| Enkephalin may mediate euphoria and drive-reduction reward | Q40068163 | ||
| Association of beta-endorphin with specific clinical symptoms of depression | Q41108575 | ||
| Acute effects of direct dopamine agonists in the mouse behavioral despair test | Q42202715 | ||
| Behavioral effects of urotensin-II centrally administered in mice | Q42667921 | ||
| Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine | Q43507105 | ||
| Behavioral and neuroendocrine actions of endomorphin-2. | Q43713616 | ||
| Mouse lines differing in sensitivity to beta-CCM differ in tasks used for testing antidepressants | Q43921739 | ||
| Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain. | Q44014658 | ||
| Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice | Q44050778 | ||
| Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system | Q44186033 | ||
| Implication of endogenous opioid system in the learned helplessness model of depression | Q44332753 | ||
| The effect of endomorphins on the release of 3H-norepinephrine from rat nucleus tractus solitarii slices | Q44332846 | ||
| Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration | Q44341731 | ||
| Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs | Q44345880 | ||
| Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat. | Q44347451 | ||
| Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor | Q44352111 | ||
| The involvement of dopamine and nitric oxide in the endocrine and behavioural action of endomorphin-1. | Q44505603 | ||
| Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse | Q44674595 | ||
| Supraspinal anti-allodynic and rewarding effects of endomorphins in rats | Q44912504 | ||
| Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position. | Q45180464 | ||
| Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent | Q46953857 | ||
| Endomorphins have orexigenic and anxiolytic activities in mice | Q47727909 | ||
| Effect of monoamine precursors on the forced-swimming test in mice | Q48152495 | ||
| A functional anatomical study of unipolar depression. | Q48433687 | ||
| Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord | Q48462762 | ||
| Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats. | Q52203785 | ||
| The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. | Q53770341 | ||
| Study of the clomipramine-morphine interaction in the forced swimming test in mice | Q70375378 | ||
| Effect of changes in swimming area on results of "behavioral despair test" | Q72620796 | ||
| 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity | Q73154073 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 813-821 | |
| P577 | publication date | 2006-07-05 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice | |
| P478 | volume | 32 |
| Q30481450 | 30 years of dynorphins--new insights on their functions in neuropsychiatric diseases |
| Q45918938 | Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. |
| Q35208485 | Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice. |
| Q41537125 | Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice |
| Q44342182 | Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression |
| Q36350793 | Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat. |
| Q46399968 | Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. |
| Q52595693 | Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery. |
| Q33920823 | Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice |
| Q28275620 | Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators |
| Q36824121 | The Association Between Midlife Physical Activity and Depressive Symptoms in Late Life: Age Gene/Environment Susceptibility-Reykjavik Study |
Search more.